Intervention Protocol

Alpha-lipoic acid for diabetic peripheral neuropathy

  1. Nasir Mirza1,*,
  2. David R Cornblath2,
  3. Syed Hasan1,
  4. Usman Hussain1

Editorial Group: Cochrane Neuromuscular Disease Group

Published Online: 21 JAN 2009

DOI: 10.1002/14651858.CD005492

Database Title

Additional Information

How to Cite

Mirza N, Cornblath DR, Hasan S, Hussain U. Alpha-lipoic acid for diabetic peripheral neuropathy (Protocol). Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD005492. DOI: 10.1002/14651858.CD005492.

Author Information

  1. 1

    National Hospital for Neurology and Neurosurgery, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, London, UK

  2. 2

    Johns Hopkins Hospital, Department of Neurology, Baltimore, Maryland, USA

*Nasir Mirza, c/o Cochrane Neuromuscular Disease Group, MRC Centre for Neuromuscular Disease, National Hospital for Neurology and Neurosurgery, PO Box 114, Queen Square, London, WC1N 3BG, UK. nasir.mirza@doctors.org.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 21 JAN 2009

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Full (136K)
 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To assess the effects of alpha-lipoic acid on symptoms, impairment and neurophysiological attributes in established diabetic peripheral neuropathy.

View Full Article (HTML) Full (136K)